Correlation Between Cns Pharmaceuticals and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Virax Biolabs Group, you can compare the effects of market volatilities on Cns Pharmaceuticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Virax Biolabs.
Diversification Opportunities for Cns Pharmaceuticals and Virax Biolabs
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cns and Virax is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Virax Biolabs go up and down completely randomly.
Pair Corralation between Cns Pharmaceuticals and Virax Biolabs
Given the investment horizon of 90 days Cns Pharmaceuticals is expected to generate 0.74 times more return on investment than Virax Biolabs. However, Cns Pharmaceuticals is 1.35 times less risky than Virax Biolabs. It trades about -0.02 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.1 per unit of risk. If you would invest 15.00 in Cns Pharmaceuticals on August 28, 2024 and sell it today you would lose (3.00) from holding Cns Pharmaceuticals or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cns Pharmaceuticals vs. Virax Biolabs Group
Performance |
| Timeline |
| Cns Pharmaceuticals |
| Virax Biolabs Group |
Cns Pharmaceuticals and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cns Pharmaceuticals and Virax Biolabs
The main advantage of trading using opposite Cns Pharmaceuticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Cns Pharmaceuticals vs. Capricor Therapeutics | Cns Pharmaceuticals vs. Soleno Therapeutics | Cns Pharmaceuticals vs. Bio Path Holdings | Cns Pharmaceuticals vs. Moleculin Biotech |
| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |